By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AmextaFinanceAmextaFinance
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Notification Show More
Aa
AmextaFinanceAmextaFinance
Aa
  • Banking
  • Credit Cards
  • Loans
  • Dept Management
  • Mortgage
  • Markets
  • Investing
  • Small Business
  • Videos
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Follow US
AmextaFinance > News > Former US president Joe Biden diagnosed with aggressive prostate cancer
News

Former US president Joe Biden diagnosed with aggressive prostate cancer

News Room
Last updated: 2025/05/18 at 4:48 PM
By News Room
Share
1 Min Read
SHARE

Unlock the White House Watch newsletter for free

Your guide to what Trump’s second term means for Washington, business and the world

Joe Biden has been diagnosed with an aggressive form of prostate cancer, a spokesperson for the former US president said.

Biden on Friday was diagnosed with the cancer, with metastasis to the bone, following findings of a prostate nodule after he experienced “increasing urinary symptoms,” Biden’s personal office said in a statement on Sunday. 

“While this represents a more aggressive form of the disease, the cancer appears to be hormone-sensitive which allows for effective management,” it added.

“The President and his family are reviewing treatment options with his physicians”. 

The news comes as the former president has in recent days returned to the spotlight after leaving office in January in an effort to defend his legacy, just as damning accounts revealed his mental decline in office and his inner circle’s efforts to conceal it.

This is a developing story

Read the full article here

News Room May 18, 2025 May 18, 2025
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Finance Weekly Newsletter

Join now for the latest news, tips, and analysis about personal finance, credit cards, dept management, and many more from our experts.
Join Now
EU will lose ‘race to the bottom’ on regulation, says competition chief

Stay informed with free updatesSimply sign up to the EU business regulation…

Why beef prices are soaring

Watch full video on YouTube

Opendoor is an AI stock: Analyst

Watch full video on YouTube

Sanofi-Dynavax: A Conservative Vaccine Deal With Upside Tail Risk (NASDAQ:SNY)

This article was written byFollowWith a background as a RN, I analyze…

Law firms hire record number of City partners as US players expand aggressively

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects…

- Advertisement -
Ad imageAd image

You Might Also Like

News

EU will lose ‘race to the bottom’ on regulation, says competition chief

By News Room
News

Sanofi-Dynavax: A Conservative Vaccine Deal With Upside Tail Risk (NASDAQ:SNY)

By News Room
News

Law firms hire record number of City partners as US players expand aggressively

By News Room
News

Narendra Modi turns his focus to reforming India’s economy

By News Room
News

Jeffrey Epstein appointed Jes Staley and Lawrence Summers as executors of his will

By News Room
News

SETM: Why This ETF Should Be Read As A Cyclical Mining Play (NASDAQ:SETM)

By News Room
News

Gold and silver hit record highs on geopolitical tensions

By News Room
News

Fraudsters use AI to fake artwork authenticity and ownership

By News Room
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Press Release
  • Contact
  • Advertisement
More Info
  • Newsletter
  • Market Data
  • Credit Cards
  • Videos

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions
Join Community

2023 © Indepta.com. All Rights Reserved.

YOUR EMAIL HAS BEEN CONFIRMED.
THANK YOU!

Welcome Back!

Sign in to your account

Lost your password?